Literature DB >> 34668949

Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity.

Marissa B Reitsma1, Jeremy D Goldhaber-Fiebert1, Joshua A Salomon1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34668949      PMCID: PMC8529412          DOI: 10.1001/jamanetworkopen.2021.30343

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

Unequal COVID-19 vaccination rates in the United States have compounded existing disparities in cases, hospitalizations, and deaths among Black and Hispanic populations.[1,2,3] In this study, we quantify how differential vaccine uptake by race and ethnicity within each US state produced substantial vaccination coverage disparities during the initial scale-up among older adults. We model alternative scenarios for the period after eligibility opened to all adults, including a scenario of persistent differential uptake and scenarios that include efforts to reduce disparities by addressing access barriers, increasing vaccine confidence, and prioritizing disadvantaged geographic areas.

Methods

For this decision analytical model, we analyzed demographic data (population distribution by age, self-reported race and ethnicity, and census tract) from the American Community Survey.[4] From state websites, we extracted shares of people receiving at least 1 vaccine dose, stratified by age and separately by self-reported race and ethnicity, through March 31, 2021 (eMethods in the Supplement). We extracted and analyzed data for American Indian or Alaska Native, Asian, Black, Hispanic, Multiracial, Native Hawaiian or Other Pacific Islander, and White populations, but we only report estimates for Asian, Black, Hispanic, and White populations based on our minimum state-level population threshold of 200 000 people. Combining these data, we estimated relative uptake rates for the initial scale-up preceding all-adult eligibility by race and ethnicity within each state. We defined relative uptake rates as the observed share of vaccinations for a racial or ethnic group divided by the expected share if uptake across racial and ethnic groups within each age group were proportional to population size. This approach allowed us to control for the interaction of age-based eligibility criteria with differing age structures by race and ethnicity and thereby isolate the effects of differential vaccination accessibility and confidence. We modeled vaccination scale-up within each census tract in a state under 3 scenarios. In the persistent differential uptake scenario, we used observed daily vaccination rates by state reported by the Centers for Disease Control and Prevention between April 1 and July 1, 2021, and assumed disparities in state-specific relative uptake rates by race and ethnicity would continue. In the equalized uptake scenario, we assumed equal vaccination rates in all racial and ethnic groups within a state, set each day as the highest rate observed for any group with a state-level population of at least 200 000 people. In the equalized uptake and geographic targeting scenario, we modeled the further impact of doubling vaccination rates in the most disadvantaged quartile of census tracts (according to the Centers for Disease Control and Prevention’s Social Vulnerability Index) during 6 weeks beginning April 1. We compared projections in the 3 scenarios to estimated levels of actual coverage by race and ethnicity as of July 1 to benchmark progress toward addressing vaccine equity.[5] All analyses were conducted using R version 4.0.3 (R Project for Statistical Computing). We did not seek institutional review board approval because our analysis only included deidentified, publicly available data that are considered exempt under the Common Rule.

Results

In most states, relative uptake rates through March 31, 2021, were substantially higher among White compared with Black and Hispanic adults, by a median factor of 1.3 times for White compared with Black adults (IQR, 1.2-1.4 times) and a median 1.3 times for White compared with Hispanic adults (IQR, 1.1-1.6 times) (Figure 1). Combined effects of disproportionate uptake and age-based eligibility resulted in estimated coverage among Black and Hispanic adults (29%) being one-third lower than among White adults (43%) by the end of March.
Figure 1.

Relative Rates of COVID-19 Vaccination Uptake by Race and Ethnicity and State, Visualized on a Log Scale

Estimates are shown for populations that exceed 200 000 people and have data available on state reporting dashboards. Relative rates of uptake are defined as the observed share of vaccinations for a racial or ethnic group, divided by the expected share if uptake across racial and ethnic groups within each age group were proportional to population size.

aState data not reported by race and ethnicity as of March 31, 2021.

Relative Rates of COVID-19 Vaccination Uptake by Race and Ethnicity and State, Visualized on a Log Scale

Estimates are shown for populations that exceed 200 000 people and have data available on state reporting dashboards. Relative rates of uptake are defined as the observed share of vaccinations for a racial or ethnic group, divided by the expected share if uptake across racial and ethnic groups within each age group were proportional to population size. aState data not reported by race and ethnicity as of March 31, 2021. In the persistent differential uptake scenario, Hispanic and Black adults would reach 50% coverage of at least 1 vaccine dose nationally 57 days and 26 days later, respectively, than White adults. In the equalized uptake scenario, delays would be reduced to 30 days for Black adults and 17 days for Hispanic adults. In the equalized uptake and geographic targeting scenario, delays to 50% coverage would narrow to 13 and 8 days for Black and Hispanic adults, respectively; in this scenario, coverage disparities between Hispanic and White adults would have been eliminated by July 1, 2021, and the coverage gap would have been reduced by 76% for Black adults (Figure 2).
Figure 2.

Coverage of 1 or More COVID-19 Vaccination Doses Among Population 18 Years and Older, by Racial or Ethnic Group, Aggregated to National Level

Panels show persistent differential uptake (A), equalized uptake (B), and equalized uptake and geographic targeting (C). Dashed lines show overall coverage among the US population aged 18 years or older.

Coverage of 1 or More COVID-19 Vaccination Doses Among Population 18 Years and Older, by Racial or Ethnic Group, Aggregated to National Level

Panels show persistent differential uptake (A), equalized uptake (B), and equalized uptake and geographic targeting (C). Dashed lines show overall coverage among the US population aged 18 years or older. Actual levels of coverage nationally on July 1 were estimated to be 68%, 67%, and 54% for Hispanic, White, and Black adults, respectively (Figure 2). Actual coverage among Black adults reached levels projected in the equalized uptake scenario in only 10 of 30 states with reported data and sufficient population size, whereas coverage among Hispanic adults reached these benchmark levels in 20 of 27 states analyzed.

Discussion

The disparities in vaccination among Black and Hispanic adults seen in this study highlight the urgent need to invest in policies and interventions to promote vaccine equity. Our results additionally demonstrate the benefits of place-based targeting of efforts to promote vaccination uptake. Limitations of this analysis include incomplete reporting of race and ethnicity in state vaccination data and lack of these data at the substate level. Nevertheless, by applying consistent rules, we reconciled heterogeneous reporting data to quantify vaccination disparities and demonstrated the need for equity-focused policies to ensure that underserved communities are not left behind.[6]
  4 in total

1.  This Time Must Be Different: Disparities During the COVID-19 Pandemic.

Authors:  Kirsten Bibbins-Domingo
Journal:  Ann Intern Med       Date:  2020-04-28       Impact factor: 25.391

2.  Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021.

Authors:  Elizabeth M Painter; Emily N Ussery; Anita Patel; Michelle M Hughes; Elizabeth R Zell; Danielle L Moulia; Lynn Gibbs Scharf; Michael Lynch; Matthew D Ritchey; Robin L Toblin; Bhavini Patel Murthy; LaTreace Q Harris; Annemarie Wasley; Dale A Rose; Amanda Cohn; Nancy E Messonnier
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-05       Impact factor: 17.586

3.  Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5-18, 2020 - 22 States, February-June 2020.

Authors:  Jazmyn T Moore; Jessica N Ricaldi; Charles E Rose; Jennifer Fuld; Monica Parise; Gloria J Kang; Anne K Driscoll; Tina Norris; Nana Wilson; Gabriel Rainisch; Eduardo Valverde; Vladislav Beresovsky; Christine Agnew Brune; Nadia L Oussayef; Dale A Rose; Laura E Adams; Sindoos Awel; Julie Villanueva; Dana Meaney-Delman; Margaret A Honein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-08-21       Impact factor: 17.586

4.  Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020.

Authors:  Jeremy A W Gold; Lauren M Rossen; Farida B Ahmad; Paul Sutton; Zeyu Li; Phillip P Salvatore; Jayme P Coyle; Jennifer DeCuir; Brittney N Baack; Tonji M Durant; Kenneth L Dominguez; S Jane Henley; Francis B Annor; Jennifer Fuld; Deborah L Dee; Achuyt Bhattarai; Brendan R Jackson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-10-23       Impact factor: 17.586

  4 in total
  11 in total

1.  Assessment of Digital and Community-Based Outreach Interventions to Encourage COVID-19 Vaccination Uptake in an Underserved Community.

Authors:  Daniela Diaz; Sharon Chacko; Anne Sperling; Elaine Fleck; Irene Louh; Richard Trepp; Siqin Ye
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2.

Authors:  Isobel Routledge; Saki Takahashi; Adrienne Epstein; Jill Hakim; Owen Janson; Keirstinne Turcios; Jo Vinden; John Tomas Risos; Margaret Rose Baniqued; Lori Pham; Clara Di Germanio; Michael Busch; Margot Kushel; Bryan Greenhouse; Isabel Rodríguez-Barraquer
Journal:  Nat Commun       Date:  2022-05-04       Impact factor: 17.694

3.  Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial.

Authors:  Cécile Janssen; Marine Cachanado; Laetitia Ninove; Marie Lachatre; Jocelyn Michon; Olivier Epaulard; Zoha Maakaroun-Vermesse; Christian Chidiac; Bruno Laviolle; Hugues Aumaitre; Ady Assaf; Karine Lacombe; Catherine Schmidt-Mutter; Elisabeth Botelho-Nevers; Magali Briere; Thomas Boisson; Paul Loubet; Boris Bienvenu; Olivier Bouchaud; Amel Touati; Christine Pereira; Alexandra Rousseau; Laurence Berard; Melissa Montil; Xavier de Lamballerie; Tabassome Simon; Odile Launay
Journal:  EClinicalMedicine       Date:  2022-05-12

4.  Error in Results.

Authors: 
Journal:  JAMA Netw Open       Date:  2021-11-01

5.  COVID-19 vaccine uptake in the US is hampered by mistrust from Black and Latinx communities.

Authors:  C Fradkin
Journal:  Public Health       Date:  2021-12-10       Impact factor: 4.984

6.  How Vaccine Ambivalence Can Lead People Who Inject Drugs to Decline COVID-19 Vaccination and Ways This Can Be Addressed: Qualitative Study.

Authors:  Ian David Aronson; Alex S Bennett; Mary-Andrée Ardouin-Guerrier; German Rivera-Castellar; Brent Gibson; Samantha Santoscoy; Brittney Vargas-Estrella
Journal:  JMIR Form Res       Date:  2022-03-23

7.  Learning from Others' Disasters? A Comparative Study of SARS/MERS and COVID-19 Responses in Five Polities.

Authors:  Eran Feitelson; Pnina Plaut; Eli Salzberger; Deborah Shmueli; Alex Altshuler; Smadar Amir; Michal Ben-Gal
Journal:  Int J Disaster Risk Reduct       Date:  2022-03-25       Impact factor: 4.842

8.  Opportunities to Improve Long COVID Care: Implications from Semi-structured Interviews with Black Patients.

Authors:  Rachel S Bergmans; Keiyana Chambers-Peeple; Deena Aboul-Hassan; Samantha Dell'Imperio; Allie Martin; Riley Wegryn-Jones; Lillian Z Xiao; Christine Yu; David A Williams; Daniel J Clauw; Melissa DeJonckheere
Journal:  Patient       Date:  2022-07-30       Impact factor: 3.481

9.  A behavior change model to address caregiver hesitancy around COVID-19 vaccination in pediatrics.

Authors:  Jordan Yeo; Caitlyn Furr Gudmundsen; Sajjad Fazel; Alex Corrigan; Madison M Fullerton; Jia Hu; Taj Jadavji; Susan Kuhn; Aliya Kassam; Cora Constantinescu
Journal:  Vaccine       Date:  2022-08-05       Impact factor: 4.169

10.  COVID-19 Vaccine Rollouts and the Reproduction of Urban Spatial Inequality: Disparities Within Large US Cities in March and April 2021 by Racial/Ethnic and Socioeconomic Composition.

Authors:  Nicholas V DiRago; Meiying Li; Thalia Tom; Will Schupmann; Yvonne Carrillo; Colleen M Carey; S Michael Gaddis
Journal:  J Urban Health       Date:  2022-02-03       Impact factor: 5.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.